# AMAZ-02 Effect on Exercise ToLerance in Healthy, Overweight Middle Aged Subjects (ATLAS Trial)

> **NCT03464500** · NA · COMPLETED · sponsor: **Amazentis SA** · enrollment: 90 (actual)

## Conditions studied

- Muscle Function, Mitochondrial Function
- Overweight
- Healthy Aging

## Interventions

- **DIETARY_SUPPLEMENT:** Mitopure 500mg
- **DIETARY_SUPPLEMENT:** Mitopure 1000mg
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03464500
- **Lead sponsor:** Amazentis SA
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-06
- **Primary completion:** 2019-09-30
- **Final completion:** 2019-09-30
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2022-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03464500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03464500, "AMAZ-02 Effect on Exercise ToLerance in Healthy, Overweight Middle Aged Subjects (ATLAS Trial)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03464500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*